Loading cancer entity…
Loading cancer entity…
Clinical trials
62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00983580 | Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | completed | Phase 2 | 107 | National Cancer Institute (NCI)NIH | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01312467 | Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 2 | Mar 5, 2019 | clinicaltrials |
| NCT00828984 | Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer | completed | Phase 2 | 87 | National Cancer Institute (NCI)NIH | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT00432913 | Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa | completed | Phase 2 / Phase 3 | 120 | S.L.A. Pharma AGINDUSTRY | 2 | Oct 17, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Sep 4, 2019source: clinicaltrials